Mesirow Financial Investment Management Equity Management Has $1.70 Million Position in HealthSouth Corporation (NYSE:HLS)
Mesirow Financial Investment Management Equity Management decreased its position in shares of HealthSouth Corporation (NYSE:HLS) by 11.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,035 shares of the company’s stock after selling 4,370 shares during the period. Mesirow Financial Investment Management Equity Management’s holdings in HealthSouth Corporation were worth $1,696,000 as of its most recent filing with the SEC.
Several other hedge funds also recently added to or reduced their stakes in HLS. Nationwide Fund Advisors boosted its position in HealthSouth Corporation by 2.7% in the first quarter. Nationwide Fund Advisors now owns 657,564 shares of the company’s stock valued at $28,150,000 after buying an additional 16,991 shares during the last quarter. State of Alaska Department of Revenue acquired a new position in HealthSouth Corporation during the first quarter valued at approximately $235,000. Legato Capital Management LLC boosted its position in HealthSouth Corporation by 5,612.1% in the first quarter. Legato Capital Management LLC now owns 59,806 shares of the company’s stock valued at $1,397,000 after buying an additional 58,759 shares during the last quarter. Louisiana State Employees Retirement System boosted its position in HealthSouth Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 22,500 shares of the company’s stock valued at $963,000 after buying an additional 300 shares during the last quarter. Finally, CWM LLC boosted its position in HealthSouth Corporation by 2.1% in the first quarter. CWM LLC now owns 6,384 shares of the company’s stock valued at $273,000 after buying an additional 130 shares during the last quarter. Institutional investors own 97.96% of the company’s stock.
HealthSouth Corporation (NYSE HLS) opened at 43.71 on Thursday. The stock has a market capitalization of $3.95 billion, a PE ratio of 15.93 and a beta of 0.61. HealthSouth Corporation has a 12-month low of $36.97 and a 12-month high of $49.71. The stock has a 50 day moving average price of $45.82 and a 200-day moving average price of $44.16.
HealthSouth Corporation (NYSE:HLS) last issued its quarterly earnings data on Monday, July 31st. The company reported $0.71 EPS for the quarter, topping analysts’ consensus estimates of $0.68 by $0.03. The company had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. HealthSouth Corporation’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.69 earnings per share. On average, equities analysts anticipate that HealthSouth Corporation will post $2.71 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be paid a $0.25 dividend. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Friday, September 29th. This represents a $1.00 dividend on an annualized basis and a yield of 2.29%. HealthSouth Corporation’s payout ratio is 35.29%.
COPYRIGHT VIOLATION WARNING: This piece of content was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/mesirow-financial-investment-management-equity-management-has-1-70-million-position-in-healthsouth-corporation-nysehls/1469125.html.
HLS has been the subject of several recent analyst reports. Piper Jaffray Companies restated a “hold” rating and set a $50.00 target price on shares of HealthSouth Corporation in a research report on Thursday, August 3rd. KeyCorp initiated coverage on HealthSouth Corporation in a research report on Thursday, June 15th. They set a “sector weight” rating for the company. BidaskClub upgraded HealthSouth Corporation from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Mizuho boosted their target price on HealthSouth Corporation from $44.00 to $47.00 and gave the stock a “neutral” rating in a research report on Monday, July 10th. Finally, Barclays PLC restated an “underweight” rating and set a $46.00 target price (up from $44.00) on shares of HealthSouth Corporation in a research report on Monday, May 1st. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $48.83.
In related news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $43.00, for a total value of $972,875.00. Following the completion of the transaction, the chief executive officer now owns 283,134 shares of the company’s stock, valued at $12,174,762. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.60% of the company’s stock.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.